Brazilian Federal Government Unwilling to Buy Chinese Vaccines, Only Buying Products Developed by British Pharmaceutical Companies and Oxford University
 
In an interview with local Brazilian media on 14th October, Sao Paulo State Health Secretary Jean Gorinchteyn confirmed that the Brazilian federal government had not appropriated funds to purchase the Wuhan Virus vaccine (CoronaVac) from China.  Clinical trials of CoronaVac are being conducted in Brazil and the Butantan Institute of Sao Paulo State is in collaboration with research and development.
 
Gorinchteyn had also stated that in an earlier Ministry of Health meeting, the Brazilian federal government had confirmed they would only purchase vaccines jointly developed by British pharmaceutical company AstraZeneca and Oxford University and were not planning on purchasing CoronaVac.   Besides the guaranteed purchase of 61 million doses of the Oxford vaccines that the Brazilian federal government had already committed to, authorities are unwilling to purchase additional vaccines, but did not explain the reason why funds were not appropriated to buy the Chinese vaccine. 
 
#WuhanVirus #Brazil #vaccines #AstraZeneca #CoronaVac #Oxford #UK  
 
Source: Stand News  #Oct16

UAE Claims 86% effectiveness of Sinopharm COVID Vaccine, Experts Question Failure to Account for Clinical Test Data

The UAE health authorities announced on Wednesday (Dec 9) that the Chinese Sinopharm COVID-19 vaccine has been tested and confirmed to be 86% effective, making it the first country in the world to certify the effectiveness of a Chinese-made vaccine. However, some academics, holding a wait-and-see attitude, believe that the UAE authorities have not provided key and detailed information, including data from the Phase 3 clinical trials.

The UAE is one of the ten countries where two of Sinopharm’ vaccines are undergoing clinical trials. UAE indicated that it had approved an interim analysis of the vaccine’s Phase 3 clinical trial data, which showed 100% effectiveness in preventing mild symptoms from turning into moderate to severe conditions. They also claimed an overall effective protection rate of 86%, adding that the vaccine poses no serious safety concerns.

The Sinopharm Group did not confirm the news or comment to the media for several hours after UAE’s announcement. The New York Times even reported that it was disconnected when it tried to reach the group on the phone. It was only at dusk on Thursday (Dec 10) that Sinopharm uploaded its vaccine registration statement for the UAE. Still, it did not provide further data on the Phase 3 tests, such as the number of people infected with the vaccine and the volunteers’ age. The group also did not make any “welcome” remarks.

#UAE #China #Sinopharm #COVID19 #Vaccines #Trials #TestData #NewYorkTimes

Source: Stand News #Dec11

https://bit.ly/3i0j9zj

The International #Olympic Committee is going to buy the Chinese Communist Party virus #vaccines from #China. But this year’s host country, Japan, is refusing to use them.

Watch full episode👉https://youtu.be/2YjhRYqM2GI

The host of the Summer #Olympics will not provide Chinese-made #vaccines to participants of the games. The same goes for the Winter Games in Beijing next year.

#Japan's Olympic Minister Tamayo Marukawa said that Chinese vaccines have not been approved for use in Japan.

Watch full episode👉https://youtu.be/2YjhRYqM2GI

A wide range of vaccines is used in many countries but is a high vaccination rate proportional to herd immunity? Here are some examples of countries injecting different types of vaccines.

#COVID19 #Vaccines #HerdImmunity #GoHKgraphics

Two weeks before announcing that the #coronavirus is contagious last January, China seemed to have already started developing corresponding #vaccines, according to official Chinese reports.

🔥Watch the full episode👉https://youtu.be/_Ir0uUYxCBQ

China administered about 265 million doses of Chinese-made #vaccines by the end of April, with over 31,000 cases of #AdverseEffects. Chinese officials say most cases were mild.

🔥Watch the full episode👉https://youtu.be/7e1BRp-AMB8

China administered about 265 million doses of Chinese-made #vaccines by the end of April, with over 31,000 cases of #AdverseEffects. Chinese officials say most cases were mild.

🔥Watch the full episode👉https://youtu.be/7e1BRp-AMB8